Status:
UNKNOWN
Palliative and Oncology Care Intervention: Symptom COACH
Lead Sponsor:
Fox Chase Cancer Center
Conditions:
Cancer of Head and Neck
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators propose to conduct the first pilot trial of a collaborative palliative and oncology care intervention for HNC patients receiving CRT to assess the feasibility and acceptability of th...
Eligibility Criteria
Inclusion
- adult patients (≥18 years) with a diagnosis of HNC for which they are undergoing CRT
- receiving all oncology care at Fox Chase Cancer Center (FCCC)
- able to speak and read in English or with assistance from an interpreter
Exclusion
- patients with prior history of HNC for which they underwent CRT
- patients with uncontrolled psychiatric disorders (psychotic disorder, bipolar disorder, major depression) or other co-morbid disease which the treating clinician believes prohibits informed consent or participation in the study
- patients enrolled on other supportive care intervention trials
Key Trial Info
Start Date :
November 7 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2022
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT03760471
Start Date
November 7 2018
End Date
November 1 2022
Last Update
February 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States, 19111-2497